Bilgrami s.m., Qureshi s.a., pervez s., abbas f. promoter hypermethylation of tumor suppressor genes correlates with tumor grade and invasiveness in patients with urothelial bladder cancer. springerplus. 2014; 3: 178. 36. dudziec e., goepel J.r., catto J.W. global epigenetic profiling in bladder cancer. epigenomics. 2011; 3 (1): 35–45. urinary biomarkers in han chinese patients with urothelial bladder cancer. oncologist. 2015; 20: 263–9. 37. scher m. <...> W., mydlo J.h., sidi a.a. et al. detecting dna methylation of the Bcl2, cdkn2a and nid2 genes in urine using a nested methylation specific polymerase chain reaction assay to predict bladder cancer. <...> Zuiverloon T.c., Beukers W., van der keur k.a., munoz J.r., Bangma c.h., lingsma h.f. et al. a methylation assay for the detection of non-muscle-invasive bladder cancer (nmiBc) recurrences in voided urine. <...> BJu int. 2012; 109 (6): 941–8. 40. garcia-Baquero r., puerta p., Beltran m., alvarez m., sacristan r., alvarez-ossorio J.l. et al. methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study. <...> J. urol. 2013; 190 (2): 723–30. 38. eissa s., swellam m., el-khouly i.m., kassim s.k., shehata h., mansour a. et al. aberrant methylation of rarb2 and apc genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer. cancer epidemiol. <...> Biomarkers prev. 2011; 20 (8): 1657–64. 46. chen h., yu y., rong s., Wang h. evaluation of diagnostic accuracy of dna methylation biomarkers for bladder cancer: a systematic review and meta-analysis. <...> Biomarkers. 2014; 19 (3): 189–97. 47. sacristan r., gonzalez c., fernandez-gomez J.m., fresno f., escaf s., sanchez-carbayo m. molecular classification <...>